Grade My Investments
HomeFree Stock Grades › VREX

Varex Imaging Corporation (VREX) Stock Grade

VREX · Healthcare

C+
Grade updated: July 18, 2026
Computed by the GradeMyInvestments scoring model from revenue growth, profitability, balance-sheet strength, and analyst targets.
Market Cap
$494.3M
P/E Ratio
Revenue Growth (YoY)
+4.1%
Net Margin
-8.3%
Return on Equity
Dividend Yield
None

About Varex Imaging Corporation's fundamentals

Varex Imaging is a medical devices company with a market capitalization of $494.3 million that generated revenue growth of 4.1% year-over-year, though the company reported a net loss with a negative net margin of -8.3% in its latest annual statement. Despite the accounting loss, the company maintains positive free cash flow, suggesting operational cash generation independent of reported earnings. The company does not pay a dividend to shareholders.

Track VREX free — no credit card required. Live grade + monthly AI report →